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Abstract
Background—Unless effective preventive strategies are implemented, aging of the population
will result in a significant worsening of the heart failure (HF) epidemic. Few data exist on whether
baseline electrocardiographic (ECG) abnormalities can refine risk prediction for HF.
Methods—We examined a prospective cohort of 2,915 participants aged 70 to 79 years without
preexisting HF, enrolled between April 1997 and June 1998 in the Health, Aging, and Body
Composition (Health ABC) study. Minnesota Code was used to define major and minor ECG
abnormalities at baseline and at year 4 follow-up. Using Cox models, we assessed (1) the
association between ECG abnormalities and incident HF and (2) the incremental value of adding
ECG to the Health ABC HF Risk Score using the net reclassification index.
Results—At baseline, 380 participants (13.0%) had minor, and 620 (21.3%) had major ECG
abnormalities. During a median follow-up of 11.4 years, 485 participants (16.6%) developed
incident HF. After adjusting for the Health ABC HF Risk Score variables, the hazard ratio (HR)
was 1.27 (95% CI 0.96–1.68) for minor and 1.99 (95% CI 1.61–2.44) for major ECG
abnormalities. At year 4, 263 participants developed new and 549 had persistent abnormalities;
both were associated with increased subsequent HF risk (HR 1.94, 95% CI 1.38–2.72 for new and
HR 2.35, 95% CI 1.82–3.02 for persistent ECG abnormalities). Baseline ECG correctly
reclassified 10.5% of patients with HF events, 0.8% of those without HF events, and 1.4% of the
overall population. The net reclassification index across the Health ABC HF risk categories was
0.11 (95% CI 0.03–0.19).
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Conclusions—Among older adults, baseline and new ECG abnormalities are independently
associated with increased risk of HF. The contribution of ECG screening for targeted prevention
of HF should be evaluated in clinical trials.
The prevalence of heart failure (HF) is rising, especially in older adults,1 and remains one of
the most frequent causes of hospitalization in persons older than 65 years.2–4 Most HF
research focuses on treatment of patients with manifest HF, but few studies have assessed
the prediction of incident HF hospitalization in primary prevention.5,6 The guidelines
emphasize the importance of identifying subjects at risk for HF at an early stage and
controlling risk factors such as hypertension, diabetes, metabolic syndrome, and
atherosclerotic disease.7,8 Subclinical changes in cardiac structure and function often
precede clinical manifestations of HF and may alter the morphology of electrocardiographic
(ECG) recording.9
Although it remains controversial whether screening ECG should be routinely done in
clinical practice,10 we11 and others12,13 have shown that resting ECG abnormalities are (1)
common among older individuals, (2) associated with incident coronary heart disease
(CHD), and (3) improve the prediction of CHD events beyond traditional risk factors.11 In
contrast, few studies have examined the association between ECG abnormalities and
incident HF,14–17 and no study has specifically assessed (1) the impact of ECG changes on
HF risk in older adults, (2) the association between dynamic ECG changes and HF risk over
time, and (3) the impact of ECG on net reclassification of HF risk beyond traditional risk
factors.5 In this study, we sought to assess the association between baseline major and minor
ECG abnormalities and the risk of incident HF among older adults in the Health, Aging, and
Body Composition Study ABC (Health ABC) as well as the risks associated with dynamic
ECG changes over time. We also evaluated the impact of ECG on reclassification in the
Health ABC HF Risk Score.5
Methods
Study design and population
We analyzed data from the Health ABC study, a prospective cohort study of 3,075
community-dwelling men and women aged 70 to 79 years enrolled between April 1997 and
June 1998 and who were without overt physical disability at enrollment. Participants were
identified from a sample of white and black Medicare-eligible adults living in designated zip
coded areas surrounding Pittsburgh, PA, and Memphis, TN. Details of eligibility and
exclusion criteria have been previously described.18 All participants gave written informed
consent, and the local institutional review boards approved the protocol. We excluded
participants with preexisting HF (97 participants), those with missing baseline HF data (43
participants), those with a pacemaker (19 participants), and those with missing baseline
ECG data (1 participant). The final sample consisted of 2,915 participants.
Electrocardiographic classification
As previously described,11 standardized procedures were used at all clinical centers for the
recording of the 12-lead resting ECGs at baseline and at the year 4 follow-up visit. Briefly, 2
trained coders read ECG records, and cases with discrepancies were resolved by a third
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senior coder. All ECGs were assessed according to the Minnesota Code, as in previous large
prospective cohorts.11,13,19–22 Electrocardiographic abnormalities were classified into minor
and major abnormalities, as previously described.11–13,21 Minor baseline ECG abnormalities
were defined as any minor ST-segment or T-wave abnormalities. Criteria for major baseline
ECG abnormalities were any of the following: (1) Q-QS wave abnormalities, (2) major ST-
T abnormalities, (3) left ventricular hypertrophy (LVH), (4) atrial fibrillation or atrial flutter,
(5) Wolff-Parkinson-White, (6) complete bundle-branch block or intraventricular block
(Supplementary Table I). Participants with both minor and major abnormalities were
classified as having major ECG abnormalities. A random sample of 5% of baseline ECG
underwent the same coding process to assess reproducibility of the readings. κ Values for
the categorization described above were 0.90 for major, 0.81 for minor, and 0.82 for no
abnormalities. At year 4, we analyzed repeat ECG data among 2,300 participants. From the
baseline sample of 2,915 participants, 212 died within the first 4 years of non-HF causes. In
addition, we excluded 59 participants who had interim HF events and 396 participants who
had no available data on ECG.
Incident HF
All participants were contacted every 6 months to report any cardiovascular events.18
Incident HF was defined as any overnight hospitalization related to HF among participants
without HF at baseline. The presence of clinical HF at baseline was based on self-reported
history, use of selected drugs, and 5-year review of Medicare data.23 The HF criteria
required at least a diagnosis of HF from a physician and treatment for HF, including current
prescription for a diuretic agent and either digitalis or vasodilator or β-blocker. Clinicians at
each center adjudicated HF events based on symptoms, clinical signs, chest x-ray, and
echocardiographic findings, using criteria similar to those used in the Cardiovascular Health
Study.24 The available data on left ventricular ejection fraction (LVEF), as assessed by
echocardiography or left ventriculography, were abstracted from medical records during the
index hospitalization for HF events. Follow-up time was defined as the time from baseline
ECG to the first HF event, death, or last contact date.
Covariates definition
The Health ABC HF Risk Score was developed in the Health ABC5 Study and validated in
the Cardiovascular Health Study to assess the 5-year risk of HF among older adults.25 The
model had a C-statistic of 0.73 in the derivation data set, 0.72 by internal validation, and
0.74 in the external validation data set. The Health ABC Risk Score classifies patients into 4
groups of 5-year HF risk (<5%, 5%–10%, 10%–20%, >20%) and includes the following
variables: age, smoking, systolic blood pressure, CHD at baseline, heart rate, fasting
glucose, LVH, serum albumin, and creatinine.
Statistical analysis
Differences in proportions and mean of covariates across participants with and without
incident HF events during follow-up were assessed using χ2 and analysis of variance
statistics, respectively. For covariates that were not normally distributed, median values with
interquartile ranges were reported and compared with the use of Mann-Whitney U statistics.
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We used Cox proportional hazards models to assess the association between ECG
abnormalities and HF events in multivariate analyses. We examined the proportionality of
hazards using graphical methods and Schoenfeld residual tests. A Fine-Gray competing risks
models treating all-cause mortality as a competing risk for HF were used to estimate
cumulative HF incidence curves.26 Estimates were adjusted for a number of confounders in
3 nested models including (1) age and sex; (2) Health ABC HF Risk Score variables5; and
(3) in secondary analyses self-reported race, total cholesterol, body mass index, alcohol
intake, and cardiovascular medications. We did not include LVH in the multivariate models
because LVH was already included as a major ECG abnormality according to Minnesota
Code. Sensitivity analyses including LVH in multivariate models showed similar results. To
explore the impact of CHD on the association between ECG abnormalities and HF, we
performed subgroup analyses according to preexisting CHD at baseline defined as the
combination of possible and definite CHD. In a secondary analysis, we evaluated the
association between ECG abnormalities and HF events with reduced (≤45%) versus
preserved (>45%) LVEF.
For the reclassification analysis, we censored follow-up participants at 5 years as previously
described.5 We classified participants into 4 groups of HF risk (<5%, 5%–10%, 10%–20%,
and >20%) according to the Health ABC HF Risk Score.5 We assessed the reclassification
among HF events and nonevents, as well among the overall population. We evaluated the
net reclassification improvement (NRI) as described by Pencina et al11,27–30 across
categories with the addition of any ECG abnormality (minor or major). This method weighs
the reclassification rates for events and nonevents equally. All analyses were performed with
Stata version 12.1 (StataCorp, College Station, TX) and R version 2.13.0 (Project for
Statistical Computing, http://www.r-project.org/). All tests were 2-sided, and P < .05 was
considered statistically significant. The National Institute of Aging funded the Health ABC
Study, reviewed the manuscript, and approved its publication.
The authors are solely responsible for the design and conduct of this analysis, all study
analyses, and drafting and editing of the manuscript.
Results
Baseline characteristics
Among 2,915 participants without preexisting HF, 1,915 (65.7%) had no ECG
abnormalities, 380 (13.0%) had minor ECG abnormalities, and 620 (21.3%) had major ECG
abnormalities (Table I). The mean age was 73.6 years, 52.2% of participants were women,
41.3% were black, and 19.4% had baseline CHD. Participants with any ECG abnormality
were older; had a higher systolic blood pressure, fasting glucose, creatinine, body mass
index, and alcohol consumption; and were more likely to be men, black, and have a history
of diabetes, hypertension, and CHD.
Electrocardiographic abnormalities and incident HF
During a median follow-up time of 11.4 years (inter-quartile range [IQR] 7.0–11.7 years),
485 participants developed incident HF. The risk of HF increased with baseline ECG
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abnormalities. The Figure shows the cumulative incidence of HF events according to the
presence of baseline ECG abnormalities. In age and gender-adjusted analyses, the hazard
ratio (HR) for HF events was 2.09 (95% CI 1.75–2.50) in those with any (minor and/or
major) ECG abnormalities compared with those without ECG abnormalities (Table II). The
risk of HF increased according to the severity of ECG abnormalities: HR was 1.54 (95% CI
1.18–2.01) for minor and 2.46 (95% CI 2.02–2.99) for major abnormalities (P value for
trend <.001). The association remained significant after adjustment for the Health ABC HF
Risk Score variables (HR 1.70, 95% CI 1.41–2.05 for any ECG abnormalities) and persisted
after additional adjustment for other potential confounding risk factors (body mass index,
race, cholesterol, and alcohol intake) and for cardiovascular medications (Online Appendix
Supplementary Table II). The Fine-Gray model treating all-cause mortality as a competing
risk yielded a subdistribution HR of 1.58 (95% CI 1.31–1.81) for any ECG abnormality,
which was similar to the estimate obtained with the main model. Self-reported race and
gender did not show significant interactions with ECG abnormalities for HF risk (P value
for interaction >.10), although the association was stronger among blacks (Online Appendix
Supplementary Table III). The association between baseline ECG abnormalities and HF
events did not significantly differ according to preexisting CHD (P value for interaction >.
20) (Table II). In secondary analyses according to LVEF on index HF admission, ECG
abnormalities at baseline were associated with risk of HF with preserved LVEF (HR 1.87,
95% CI 1.38–2.53) and reduced LVEF (HR 2.68, 95% CI 2.04–3.54) (Online Appendix
Supplementary Table IV).
Reclassification
Among the 2,835 participants with complete data on covariates, 172 participants had HF
events during the first 5 years of follow-up. The addition of ECG abnormalities to the Health
ABC HF Risk Score resulted in an NRI of 0.11 (95% CI 0.03–0.19, P = .005) (Table III).
Electrocardiogram correctly reclassified 10.5% of participants with HF events, 0.8% of
those without HF events, and 1.4% of the overall population. There was no evidence of a
violation of the proportional assumptions through graphical assessment and using
Schoenfeld's test and the NRI was similar in sensitivity analyses dealing with censoring.
New ECG changes and HF risk
Among 2,248 participants who did not have an HF event before the year 4 follow-up, 1,269
(56.5%) had normal ECG in both examinations (baseline and year 4), 167 (7.4%) had
abnormalities at baseline only, 263 (11.7%) had new abnormalities at year 4, and 549
(24.4%) had persistent abnormalities at both examinations (Online Appendix Supplementary
Table V). During a median follow-up of 8.5 years (IQR 6.0–8.7 years) after the second
ECG, 328 participants had incident HF. The risk of HF events increased both with new and
persistent ECG abnormalities. Online Appendix Supplementary Figure shows the
cumulative incidence after the second ECG according to normal ECG, baseline, incident,
and persistent ECG abnormalities. In age- and gender-adjusted analyses, HR was 1.93 (95%
CI 1.38–2.69) for new ECG abnormalities and 2.67 (95% CI 2.10–3.41) for persistent ECG
abnormalities (P value for trend <.001). Risks did not significantly differ according to
preexisting CHD at 4 years (P value for interaction >.20).
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Discussion
Main findings
In this prospective cohort study, baseline ECG abnormalities in older adults were associated
with an increased risk of incident HF after adjustment for clinical HF risk factors. The risk
of HF increased significantly with the severity of ECG abnormalities. The association
persisted after excluding participants with CHD at baseline and was present for HF with
preserved and reduced LVEF. The addition of ECG data reclassified participants with HF
events in higher risk categories, but its impact was modest regarding the entire population.
New or persistent ECG abnormalities at 4 years were also associated with an increased risk
of incident HF events.
Previous studies
A previous analysis in the same cohort has reported that ECG abnormalities were associated
with incident CHD.11 In this study, we reported that the same abnormalities were associated
with HF events even in the absence of known CHD. Few studies have previously examined
the associations between ECG changes and incident HF, and none examined specifically
older (>70 years) adults.14,16,17 In a middle-aged adult cohort (the Multi-Ethnic Study of
Atherosclerosis), a long QRS duration >100 ms was significantly associated with incident
HF suggesting that ECG abnormalities might be a marker of ventricular structural changes
in asymptomatic subjects.9
Strengths and limitations
This study has several strengths and limitations. The data were drawn from a well-
characterized cohort of older adults with a large number of HF events over 11 years of
follow-up. However, participants were selected based on no disability at baseline, and
therefore, this cohort might not be fully representative of the general older adult population.
All HF events were adjudicated by independent reviewers. However, HF events were based
on hospital admissions, which might underestimate the true incidence of HF. Nevertheless,
this should similarly affect all ECG groups. Although ECG records were reviewed by 2
trained coders,11 the reproducibility and reclassification using ECG might be lower in the
clinical setting.31 We also had limited power to perform analyses considering each specific
ECG abnormality. We assessed the reclassification improvement with ECG using the Health
ABC HF Risk Score with a follow-up of 5 years. Using Cox regression models over a longer
follow-up period might violate the assumption of nonproportionality, but we did not find
evidence of nonproportionality in our models. Finally, our results might not be applicable to
individuals younger than 70 years old.
Clinical implications
In our study, ECG improved modestly classification in the overall sample across categories
of the Health ABC HF Risk Score over 5 years. The Health ABC HF Risk Score aims to
evaluate the individual HF risk over 5 years to target those who should benefit from
intensive preventive efforts. Our study suggests that the presence of ECG abnormalities
might be an independent risk factor for HF. Traditional risk factors as well ECG
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abnormalities change and modify the risk of HF over time and should be assessed regularly.
The American College of Cardiology/American Heart Association HF staging classification
defines stage A as individuals at risk for HF without structural heart disease and stage B as
individuals with structural heart disease but without clinical symptoms of HF.7 Early
detection of structural heart changes by ECG holds promise for an improved classification of
HF risk at the population level. Electrocardiographic abnormalities might precede clinical
manifestation of HF even in the absence of clinical CHD. A strategy based on ECG
screening in asymptomatic older individuals and further investigation (echocardiography,
Brain natriuretic peptide) for those with abnormalities should be assessed in a prospective
trial.32 Echocardiographic abnormalities in asymptomatic subjects have been associated with
HF events even in patients without ECG abnormalities, suggesting that both tests could add
complementary information for HF risk prediction.9,32,33
Conclusions
In conclusion, ECG abnormalities are independently associated with risk of incident HF
events in older adults. The addition of ECG information improves modestly risk
reclassification for HF over routine clinical risk factors. Given its safety, noninvasive nature,
low cost, and wide availability, ECG might be a useful test to identify subjects at risk for HF
who might benefit from further investigations and preventive efforts. The contribution of
ECG in the prevention of HF among asymptomatic subjects should be evaluated further in
randomized controlled trials.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure.
Cumulative incidence of HF events according to the presence of baseline ECG
abnormalities.
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Table II
Hazard ratios for HF events according to ECG abnormalities (N = 2,915)
ECG abnormalities
No. of
HF events
No. of
participants
HR adjusted for age
and gender (95% CI)
HR adjusted for Health ABC HF
Risk Score variables* (95% CI)
No ECG abnormalities 246 1915 1 (ref) 1 (ref)
Minor ECG abnormalities 69 380 1.54 (1.18–2.01) 1.27 (0.96–1.68)
Major ECG abnormalities 170 620 2.46 (2.02–2.99) 1.99 (1.61–2.44)
P for trend <.001 <.001
Any ECG abnormality 239 1000 2.09 (1.75–2.50)† 1.70 (1.41–2.05)†
*Age, CHD, systolic blood pressure, heart rate, smoking, albumin, fasting glucose, creatinine. Eighty participants had missing data. Left ventricular
hypertrophy was not included in the multivariate models, as LVH was classified as major abnormalities.
†
The interaction test according to preexisting CHD was not significant (P = .545). See Online Appendix Supplementary Table III.
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